HMGB1 and early-onset autosomal dominant Alzheimer disease: The antibody crosses blood–brain barrier (BBB) at the efficiency of 2–8% antibody concentration ratio from plasma to cerebral cortex tissue (Tanaka, H. et al. HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheimer’s disease pathology.